Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

See Detailed Description

NCT00332319 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00332319
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00332319 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
See Detailed Description
Lead sponsor
GlaxoSmithKline
Phase
Phase 2
Overall status
Terminated
Start date
January 31, 2006
Completion date
February 28, 2007
Enrollment
1 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

incontinence, urinary and urinary bladder, overactive, overactive bladder